Koseoglu N, Wang J, Anokye-Danso F, Amezcua Moreno J, Cha E, Fuchs F
Sci Rep. 2025; 15(1):8498.
PMID: 40075217
PMC: 11904190.
DOI: 10.1038/s41598-025-93562-9.
Heinken A, Asara J, Gnanaguru G, Singh C
Commun Biol. 2025; 8(1):25.
PMID: 39789310
PMC: 11718186.
DOI: 10.1038/s42003-024-07394-w.
Tang W, Zhang Y, Zhang H, Li K, Zhao Z, Ma H
Biomed Rep. 2024; 21(2):111.
PMID: 38912168
PMC: 11190637.
DOI: 10.3892/br.2024.1799.
Choubey M, Tirumalasetty M, Bora N, Bora P
Biomedicines. 2023; 11(11).
PMID: 38002042
PMC: 10668948.
DOI: 10.3390/biomedicines11113044.
An Y, Cao B, Li K, Xu Y, Zhao W, Zhao D
J Diabetes Res. 2023; 2023:8831609.
PMID: 37920605
PMC: 10620016.
DOI: 10.1155/2023/8831609.
Emerging Role of Adiponectin/AdipoRs Signaling in Choroidal Neovascularization, Age-Related Macular Degeneration, and Diabetic Retinopathy.
Choubey M, Bora P
Biomolecules. 2023; 13(6).
PMID: 37371562
PMC: 10296745.
DOI: 10.3390/biom13060982.
Potential Protective Function of Adiponectin in Diabetic Retinopathy.
Deng H, Ai M, Cao Y, Cai L, Guo X, Yang X
Ophthalmol Ther. 2023; 12(3):1519-1534.
PMID: 37000404
PMC: 10164206.
DOI: 10.1007/s40123-023-00702-3.
FGF21 via mitochondrial lipid oxidation promotes physiological vascularization in a mouse model of Phase I ROP.
Fu Z, Lundgren P, Pivodic A, Yagi H, Harman J, Yang J
Angiogenesis. 2023; 26(3):409-421.
PMID: 36943533
PMC: 10328855.
DOI: 10.1007/s10456-023-09872-x.
The role of the mTOR pathway in diabetic retinopathy.
Casciano F, Zauli E, Rimondi E, Mura M, Previati M, Busin M
Front Med (Lausanne). 2022; 9:973856.
PMID: 36388931
PMC: 9663464.
DOI: 10.3389/fmed.2022.973856.
Adiponectin Ameliorates Hyperglycemia-Induced Retinal Endothelial Dysfunction, Highlighting Pathways, Regulators, and Networks.
Bushra S, Al-Sadeq D, Bari R, Sahara A, Fadel A, Rizk N
J Inflamm Res. 2022; 15:3135-3166.
PMID: 35662872
PMC: 9156523.
DOI: 10.2147/JIR.S358594.
Dapagliflozin protects neural and vascular dysfunction of the retina in diabetes.
Luo Q, Leley S, Bello E, Dhami H, Mathew D, Bhatwadekar A
BMJ Open Diabetes Res Care. 2022; 10(3).
PMID: 35577387
PMC: 9114950.
DOI: 10.1136/bmjdrc-2022-002801.
Metabolism in Retinopathy of Prematurity.
Tomita Y, Usui-Ouchi A, Nilsson A, Yang J, Ko M, Hellstrom A
Life (Basel). 2021; 11(11).
PMID: 34832995
PMC: 8620873.
DOI: 10.3390/life11111119.
Serum and aqueous humor adiponectin levels correlate with diabetic retinopathy development and progression.
Yang H, Choi Y, Han H, Kim H, Park S, Lee K
PLoS One. 2021; 16(11):e0259683.
PMID: 34780524
PMC: 8592425.
DOI: 10.1371/journal.pone.0259683.
Metabolomics in Diabetic Retinopathy: A Systematic Review.
Hou X, Wang Y, Pan C
Invest Ophthalmol Vis Sci. 2021; 62(10):4.
PMID: 34347011
PMC: 8340662.
DOI: 10.1167/iovs.62.10.4.
Potential Effects of Nutraceuticals in Retinopathy of Prematurity.
Tsang J, Wolf S, Pompoes I, Joussen A, Lam W, Yang D
Life (Basel). 2021; 11(2).
PMID: 33499180
PMC: 7912639.
DOI: 10.3390/life11020079.
Causal Relationship between Adiponectin and Diabetic Retinopathy: A Mendelian Randomization Study in an Asian Population.
Huang Y, Chang Y, Cheng C, Wu C, Liao W, Tsai F
Genes (Basel). 2020; 12(1).
PMID: 33374471
PMC: 7823606.
DOI: 10.3390/genes12010017.
Inflammation and diabetic retinopathy.
Ucgun N, Zeki-Fikret C, Yildirim Z
Mol Vis. 2020; 26:718-721.
PMID: 33209014
PMC: 7655973.
Oxidative Stress Markers and the Retinopathy of Prematurity.
Graziosi A, Perrotta M, Russo D, Gasparroni G, DEgidio C, Marinelli B
J Clin Med. 2020; 9(9).
PMID: 32825796
PMC: 7563779.
DOI: 10.3390/jcm9092711.
Targeting Neuroinflammation in Neovascular Retinal Diseases.
Wang T, Tsirukis D, Sun Y
Front Pharmacol. 2020; 11:234.
PMID: 32210818
PMC: 7076162.
DOI: 10.3389/fphar.2020.00234.
Targeting Neurovascular Interaction in Retinal Disorders.
Fu Z, Sun Y, Cakir B, Tomita Y, Huang S, Wang Z
Int J Mol Sci. 2020; 21(4).
PMID: 32098361
PMC: 7073081.
DOI: 10.3390/ijms21041503.